Nov 12, 2025 by Nathan Gray, CRTonline.org
Patients with degenerative mitral regurgitation (DMR) have similar 1-year survival, safety and quality-of-life gains after mitral valve transcatheter edge-to-edge repair (M-TEER) regardless of baseline extramitral cardiac damage stage (EMCD), including those with advanced right ventricular dysfunction, according to a new analysis from the CLASP IID randomized trial.